Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast cancer female patients: a real-world study
Abstract Aim To investigate the impact of tamoxifen dose, CYP2D6 inhibitors, CYP2D6*4 genotype, and non-genetic parameters on the outcomes of tamoxifen treated female breast cancer patients. Method We retrospectively included 3218 female patients who initiated tamoxifen following a diagnosis of brea...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-06-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12885-025-14162-4 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
